The Enalapril Use in Arterial Hypertension Stimulates The Reparative Processes in Fractures of The Proximal Femur

Mykyta Valilshchykov, Volodymyr Babalyan, Тetiana Markina, Marina Kumetchko, Liudmyla Boiko, Sergey Romaev


BACKGROUND: In patients with a fracture of the proximal femur and concomitant arterial hypertension, there is a disturbance of the reparative processes of bone tissue. This research aimed to study the regulation of the reparative processes of fractures of the proximal femur with intramedullary osteosynthesis during the correction of concomitant hypertension, which was examined based on some markers using the rat model.

METHODS: The study involved healthy Wistar rats and spontaneously hypertensive rats (SHR). The subjects were then grouped into healthy rats without exposure (1.1) SHR without exposure (2.1), healthy rats with modeled fractures of the proximal femur (1.2), SHR with modeled fractures of the proximal femur (2.2), SHR underwent hypertension correction with enalapril in subgroups without fracture (2.3) and SHR underwent hypertension correction with enalapril in subgroups with fracture (2.4). The levels of interleukin (IL)-6, tumor necrosis factor alpha (TNF-a), IL-10, amino-terminal propeptide procollagen type III (PIIINP), glucose, uric acid, creatinine, urea, cholesterol, and albumin were determined in the blood serum of the animals. Femur preparations were examined after the removal of intramedullary fixation.

RESULTS: Serum IL-6 level of animal in group 2.4 (2.297±0.361 pg/mL) were reduced compared to the corresponding indicators of rats in group 2.3 (4.054±0.491 pg/mL, p<0.05). Serum glucose and urea levels of animal in group 2.4 (3.951±0.156 mmol/L, 6.552±0.426 mmol/L, respectively) were significantly reduced in comparison with the group 2.3 (6.384±0.890 mmol/L, 10.369±0.888 mmol/L, respectively). The histological results indicated a positive effect of the drug enalapril on the healing of fractures of the proximal femur in animals with hypertension.

CONCLUSION: Correction of arterial hypertension with enalapril in fractures of the proximal femur improves the reparative processes of bone tissue.

KEYWORDS: injury healing, remodeling, concomitant diseases, angiotensin-converting enzyme inhibitors, cytokines, growth factor, collagen, biochemical parameters


Full Text:



Ganse B, Böhle F, Pasto, T, Gueorguiev B, Altgassen S, Gradl G, et al. Microcirculation after trochanteric femur fractures: a prospective cohort study using non-invasive laser-doppler spectrophotometry. Front Physiol. 2019; 10: 236, CrossRef.

Saribal D, Hocaoglu-Emre FS, Erdogan S, Bahtiya, N, Caglar Okur S, Mert M. Inflammatory cytokines IL-6 and TNF-α in patients with hip fracture. Osteoporos Int. 2019; 30(5): 1025–31, CrossRef.

The SPRINT Research Group. A randomized trial of intensive versus standard blood-pressure control. N Engl J Med. 2015; 373(22): 2103–16, CrossRef.

Rachid MA, da Silva Camargos ER, Marzano LAS, da Silva Oliveira B, Ferreira RN, Martinelli PM, et al. Effect of blockade of nitric oxide in heart tissue levels of renin angiotensin system components in acute experimental Chagas disease. Life Sci. 2019; 219: 336–42, CrossRef.

Momenzadeh M, Khosravian M, Lakkakula BVKS. Potential of renin-angiotensin system inhibition to improve metabolic bone disorders. J Nephropharmacol. 2021; 10(2): e16, CrossRef.

Bayar A, Turan A, Gülle K, Akpolat M, Turan İ, Turhan E. The effects of the angiotensin converting enzyme inhibitor enalapril and the angiotensin II type 1 receptor blocker losartan on fracture healing in rats. Clin Invest Med. 2015; 38(4): E164–72, CrossRef.

Babalyan V, Valilshchykov M, Pavlov S, Koshevaya E, Fedota O. Study of bone tissue reparation after a femur fracture depending on the correction of arterial hypertension in model object rattus norvegicus (rat gray). Georgian Med News. 2019; 1(286): 72–7, PMID.

Marsell R, Einhorn TA. The biology of fracture healing. Injury. 2011; 42(6): 551–5, CrossRef.

Maruyama M, Rhee C, Utsunomiya T, Zhang N, Ueno M, Yao Z, et al. Modulation of the Inflammatory Response and Bone Healing. Front Endocrinol. 2020; 11: 386, CrossRef.

Einhorn TA, Gerstenfeld LC. Fracture healing: mechanisms and interventions. Nat Rev Rheumatol. 2015; 11(1): 45–54, CrossRef.

Harmer D, Falank C, Reagan MR. Interleukin-6 interweaves the bone marrow microenvironment, bone loss, and multiple myeloma. Front Endocrinol. 2019; 9: 788, CrossRef.

Nishikai-Yan Shen T, Kanazawa S, Kado M, Okada K, Luo L, Hayashi A, et al. Interleukin-6 stimulates Akt and p38 MAPK phosphorylation and fibroblast migration in non-diabetic but not diabetic mice. PLoS One. 2017; 12(5): e0178232, CrossRef.

Kaiser K, Prystaz K, Vikman A, Haffner-Luntze, M, Bergdolt S, Strauss G, et al. Pharmacological inhibition of IL-6 trans-signaling improves compromised fracture healing after severe trauma. Naunyn Schmiedebergs Arch Pharmacol. 2018; 391(5): 523–36, CrossRef.

Diah M, Rahmawati, Lelo A, Muhktar Z, Lindarto D, Sandra F. Comparison of tumor necrosis factor-α level in coronary artery disease and coronary slow flow of thrombolysis in myocardial infarction. Indones Biomed J. 2019; 11(3): 299–303, CrossRef.

Chow SK, Chim YN, Wang JY, Wong RM, Choy VM Cheung WH. Inflammatory response in postmenopausal osteoporotic fracture healing. Bone Joint Res. 2020; 9(7): 368–85, CrossRef.

Pavlov SB, Babenko NM, Kumetchko MV, Litvinova OB, Semko NG, Mikhaylusov RN. The influence of photobiomodulation therapy on chronic wound healing. Rom Rep Phys. 2020; 72: 609, article.

Ono T, Takayanagi H. Osteoimmunology in bone fracture healing. Curr Osteoporos Rep. 2017; 15(4): 367–75, CrossRef.

Chen E, Liu G, Zhou X, Zhang W, Wang C, Hu D, et al. Concentration-dependent, dual roles of IL-10 in the osteogenesis of human BMSCs via P38/MAPK and NF-kappaB signaling pathways. FASEB J. 2018; 32: 4917–29, CrossRef.

Larsen JB, Knudsen CS, Parkner T. Procollagen III, N-terminal propeptide (PIIINP): establishment of reference intervals in Northern European adults and children using the MAGLUMI 800 chemiluminescence immunoassay. Scand J Clin Lab Invest. 2021; 81(5): 389–93, CrossRef.

Seebeck P, Bail HJ, Exner C, Schell H, Michel R, Amthauer H, et al. Do serological tissue turnover markers represent callus formation during fracture healing? Bone. 2005; 37(5): 669–77, CrossRef.

National Research Council. Guide for the Care and Use of Laboratory Animals: Eighth Edition. Washington DC: The National Academies Press; 2011, article.

Sarkisov DS, Perov JuL, editors. [Microscopic Technology: A Guide for Doctors and Laboratory Assistants]. Moscow: Medicine; 1996.

Pullamsetti SS, Seeger W, Savai R. Classical IL-6 signaling: a promising therapeutic target for pulmonary arterial hypertension. J Clin Invest. 2018; 128(5): 1720–23, CrossRef.

Kartika RW, Alwi I, Suyatna FD, Yunir E, Waspadji S, Immanuel S, et al. Advance-platelet rich fibrin and hyaluronic acid combination improves interleukin-6 and granulation index in diabetic foot ulcer patients. Indones Biomed J. 2021; 13(2): 170–7, CrossRef.

Pavlov SB, Kumechko MV, Litvinova OB, Babenko NM, Goncharova AV. Bone regulatory mechanisms destruction in experimental chronic kidney disease. Fiziol Zh. 2016; 62(3): 54–9, CrossRef.

Karnes JM, Daffner SD, Watkins CM. Multiple roles of tumor necrosis factor-alpha in fracture healing. Bone. 2015; 78: 87–93, CrossRef.

Pesic G, Jeremic J, Nikolic T, Zivkovic V, Srejovic I, Vranic A, et al. Interleukin-6 as possible early marker of stress response after femoral fracture. Mol Cell Biochem. 2017; 430(1–2): 191–9, CrossRef.

Chow SK, Chim YN, Wang J, Zhang N, Wong RM, Tang N, et al. Vibration treatment modulates macrophage polarisation and enhances early inflammatory response in oestrogen-deficient osteoporotic-fracture healing. Eur Cell Mater. 2019; 38: 228–45, CrossRef.

Tiyasatkulkovit W, Promruk W, Rojviriya C, Pakawanit P, Chaimongkolnukul K, Kengkoom K, et al. Impairment of bone microstructure and upregulation of osteoclastogenic markers in spontaneously hypertensive rats. Sci Rep. 2019; 9(1); 12293, CrossRef.

Stoffel K, Engler H, Kuster M, Riesen W. Changes in biochemical markers after lower limb fractures. Clin Chem. 2007; 53(1): 131–4, CrossRef.

Erotokritou-Mulligan I, Bassett EE, Bartlett C, Cowan D, McHugh C, Seah R, et al. The effect of sports injury on insulin-like growth factor-I and type 3 procollagen: implications for detection of growth hormone abuse in athletes. J Clin Endocrinol Metab. 2008; 93(7): 2760–63, CrossRef.

Kurdy NM. Serology of abnormal fracture healing: the role of PIIINP, PICP, and BsALP. J Orthop Trauma. 2000; 14(1): 48–53, CrossRef.

Sousa CP, Lopez-Peña M, Guzón FM, Abreu HV, Luís MR, Viegas CA, et al. Evaluation of bone turnover markers and serum minerals variations for predicting fracture healing versus non-union processes in adult sheep as a model for orthopedic research. Injury. 2017; 48(8): 1768–75, CrossRef.

Zhu J, Thompson CB. Metabolic regulation of cell growth and proliferation. Nat Rev Mol Cell Biol. 2019; 20(7): 436–50, CrossRef.

Hutapea RD, Widaningsih Y, Mangarengi F, Muhadi D. Analysis of urea, creatinine, and platelet indices in hypertensive patients. Indones J Clinical Pathol Med Laboratory. 2021; 27(2): 117–21, CrossRef.

Sheikh HQ, Hossain FS, Aqil A, Akinbamijo B, Mushtaq V, Kapoor H. A Comprehensive analysis of the causes and predictors of 30-day mortality following hip fracture surgery. Clin Orthop Surg. 2017; 9(1): 10–18, CrossRef.

Porter CJ, Moppett IK, Juurlink I, Nightingale J, Moran CG, Devonald MAJ. Acute and chronic kidney disease in elderly patients with hip fracture: prevalence, risk factors and outcome with development and validation of a risk prediction model for acute kidney injury. BMC Nephrol. 2017; 18: 20, CrossRef.

Demirel E, Şahin A. Predictive value of blood parameters and comorbidities on three-month mortality in elderly patients with hip fracture. Cureus. 2021; 13(10): e18634, CrossRef.

Liu CW, Ke SR, Tseng GS, Wu YW, Hwang JJ. Elevated serum uric acid is associated with incident hypertension in the health according to various contemporary blood pressure guidelines. Nutr Metab Cardiovasc Dis. 2021; 31(4): 1209–18, CrossRef.

Preyer O, Concin H, Nagel G, Zitt E, Ulmer H, Brozek W. Serum uric acid is associated with incident hip fractures in women and men – Results from a large Austrian population-based cohort study. Maturitas. 2021; 148: 46–53, CrossRef.

Bohl DD, Shen MR, Hannon CP, Fillingham YA, Darrith B, Della Valle CJ. Serum albumin predicts survival and postoperative course following surgery for geriatric hip fracture. J Bone Joint Surg Am. 2017; 99(24): 2110–18, CrossRef.

Arques S. Human serum albumin in cardiovascular diseases. Eur J Intern Med. 2018; 52: 8–12, CrossRef.

Kunutsor SK, Voutilainen A, Whitehouse MR, Seidu S, Kauhanen J, Blom AW, et al. Serum albumin and future risk of hip, humeral, and wrist fractures in Caucasian men: new findings from a prospective cohort study. Med Princ Pract. 2019; 28(5): 401–9, CrossRef.


Copyright (c) 2022 The Prodia Education and Research Institute

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


Indexed by:






The Prodia Education and Research Institute